Natco Pharma

Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer

Dismisses patent suit filed by FMC Corporation

Breckenridge and Natco did not divulge any more details regarding the launch date for the product

The company has received approval for Molnupiravir capsules (200 mg), which would be sold under brand name Molnunat in the country

The company has launched the product under the brand name Tipanat in a pack of 20 tablets in a bottle, Natco Pharma said in a…

The parties have received final approval for 10 mg and 60 mg strengths of the product and tentative approval for 30 mg strength of…

They are used to treat various types of cancers

First patient was dosed at Yashoda Hospitals, Hyderabad

He said that existing pharma companies have already started ramping up the production of the drug which is key for treating…

Lilly had also signed voluntary license agreements with Cipla, Lupin, Sun Pharma, Dr Reddy’s, MSN Labs and Torrent Pharma